20 March 2017
A CSaP Policy Workshop to brainstorm ideas on how the NIHR can measure the impact of its interventions brought together academic experts with senior policy makers for an exploratory discussion.
13 March 2017
The 2017 CSaP Annual Lecture was delivered by Professor Christopher Whitty, Chief Scientific Adviser to the Department of Health, who made his predictions about the future of health in the UK.
5 December 2016
The replacement of driving with active forms of travel has the capacity to provide myriad health and economic benefits, says Dr David Ogilvie of the Centre for Diet and Activity Research at a recent CSaP event.
2 November 2016
The strategic challenges for the economic sustainability of the NHS was the topic of conversation at a recent CSaP Policy Fellow event held in the Department of Health
10 October 2016
Decisions relating to the patenting of genomics medicine technology were debated at a recent CSaP Policy workshop on precision medicine and intellectual property.
4 October 2016
A new annual report titled Insights for Impact has been compiled and published by the Department of Psychology at the University of Cambridge to highlight the influence that recent psychological research could have in policy.
8 August 2016
Case study on meningitis vaccinations from Public Health: Research into Policy project.
9 May 2016
Professor Linda Bauld, a former scientific adviser on tobacco control to the UK government, delivered the BHRU annual lecture which this year focused on e-cigarettes and their effectiveness in smoking cessation.
29 February 2016
A Policy Workshop held in collaboratioin with Friends of the Earth, the Nesta Health Lab and the Cambridge Institute of Public Health, brought together a wide range of Policy Fellows from the health and environment sectors to discuss the role of social movements, innovation, and impact at scale.
1 February 2016
A Policy Workshop organised in partnership with the Centre for Law, Medicine and Life Sciences brought together experts from the public and private sectors working on issues around genomics, synthetic biology, intellectual property (IP) law and policy.